|Bid||3.1500 x 1100|
|Ask||3.1900 x 1100|
|Day's Range||3.1101 - 3.2500|
|52 Week Range||1.6500 - 6.1300|
|Beta (5Y Monthly)||0.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for NEXTLearn more
U.S. stock futures jumped on Monday as investors await comments from the Fed members at an Official Monetary and Financial Institutions Forum panel, to be held virtually. Additionally, the monthly Chicago Fed National Activity Index for May will be released today. S&P, Dow, and Nasdaq futures were in the green at the time of writing, with 0.5%, 0.3%, and 0.3% higher trading, respectively. NextDecade Corporation (NEXT), Pluristem Therapeutics (PSTI), Avenue Therapeutics Inc. (ATXI), and Hancock J
Wall Street still has a huge amount of influence over stocks. On Tuesday, a couple of stocks stood out in getting attention from Wall Street pros. With the Dow Jones Industrial Average (DJINDICES: ^DJI), S&P 500 (SNPINDEX: ^GSPC), and Nasdaq Composite (NASDAQINDEX: ^IXIC) all seeing modest gains on the day, the moves for Generac Holdings (NYSE: GNRC) and NextDecade (NASDAQ: NEXT) were notable and raised some eyebrows among market participants.
Shares of NextDecade (NASDAQ: NEXT) catapulted more than 53% by 10:30 a.m. EDT on Tuesday. An analyst from Evercore ISI upgraded NextDecade from in-line to outperform. Fueling that upgrade is the analyst's increasingly bullish view of the LNG market, which they see shifting in favor of developers along the U.S. Gulf Coast.